-
公开(公告)号:US20060287283A1
公开(公告)日:2006-12-21
申请号:US11330700
申请日:2006-01-12
申请人: Victor Amoo , Haregewein Assefa , Beena Bhatia , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak Kim , Rachid Mechiche , Kwasi Ohemeng , Jingwen Pan
发明人: Victor Amoo , Haregewein Assefa , Beena Bhatia , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak Kim , Rachid Mechiche , Kwasi Ohemeng , Jingwen Pan
IPC分类号: A61K31/65 , C07C237/26
CPC分类号: C07C271/54 , C07C237/26 , C07C271/22 , C07C275/30 , C07C2601/14 , C07C2603/46 , C07D211/18
摘要: The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline compounds, methods of using the compounds, and pharmaceutical compositions containing them.
摘要翻译: 本发明涉及9-氨基甲基取代的四环素化合物的前药,使用该化合物的方法和含有它们的药物组合物。
-
公开(公告)号:US20050137174A1
公开(公告)日:2005-06-23
申请号:US10877454
申请日:2004-06-25
申请人: Kwasi Ohemeng , Victor Amoo , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak Kim , Rachid Mechiche , Jingwen Pan
发明人: Kwasi Ohemeng , Victor Amoo , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak Kim , Rachid Mechiche , Jingwen Pan
IPC分类号: C07C237/26 , C07C271/22 , C07C271/54 , C07C275/28 , C07C275/30 , C07D211/18 , A61K31/65
CPC分类号: C07D211/18 , C07C237/26 , C07C271/22 , C07C271/54 , C07C275/28 , C07C275/30 , C07C2601/14 , C07C2603/46
摘要: The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline compounds, methods of using the compounds, and pharmaceutical compositions containing them.
摘要翻译: 本发明涉及9-氨基甲基取代的四环素化合物的前药,使用该化合物的方法和含有它们的药物组合物。
-
公开(公告)号:US20100249076A1
公开(公告)日:2010-09-30
申请号:US12793481
申请日:2010-06-03
申请人: Victor Amoo , Haregewein Assefa , Beena Bhatia , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak K. Kim , Rachid Mechiche , Kwasi Ohemeng , Jingwen Pan
发明人: Victor Amoo , Haregewein Assefa , Beena Bhatia , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Oak K. Kim , Rachid Mechiche , Kwasi Ohemeng , Jingwen Pan
IPC分类号: A61K31/65 , C07C237/26 , A61P31/12 , A61P33/00 , A61P31/04
CPC分类号: C07C271/54 , C07C237/26 , C07C271/22 , C07C275/30 , C07C2601/14 , C07C2603/46 , C07D211/18
摘要: The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline compounds, methods of using the compounds, and pharmaceutical compositions containing them.
摘要翻译: 本发明涉及9-氨基甲基取代的四环素化合物的前药,使用该化合物的方法和含有它们的药物组合物。
-
公开(公告)号:US20050143352A1
公开(公告)日:2005-06-30
申请号:US10877928
申请日:2004-06-25
申请人: Mark Nelson , Kwasi Ohemeng , Paul Abato , Victor Amoo , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Ismail , Oak Kim , Jude Mathews , Rachid Mechiche
发明人: Mark Nelson , Kwasi Ohemeng , Paul Abato , Victor Amoo , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Ismail , Oak Kim , Jude Mathews , Rachid Mechiche
IPC分类号: C07C237/26 , C07C271/22 , C07C271/54 , C07C275/28 , C07C275/30 , A61K31/65 , C07D221/18
CPC分类号: C07C237/48 , A61K31/65 , C07C237/26 , C07C271/22 , C07C271/54 , C07C275/28 , C07C275/30 , C07C2601/02 , C07C2601/14 , C07C2601/16 , C07C2603/46 , Y02A50/411 , Y02A50/473
摘要: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
摘要翻译: 本发明至少部分地涉及新的取代的四环素化合物。 这些四环素化合物可用于治疗许多四环素化合物反应状态,例如细菌感染和肿瘤,以及四环素化合物的其它已知应用,例如阻断四环素外排和调节基因表达。
-
公开(公告)号:US08466132B2
公开(公告)日:2013-06-18
申请号:US11258622
申请日:2005-10-25
申请人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng , Jingwen Pan
发明人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng , Jingwen Pan
IPC分类号: A61K31/65 , C07C237/26
CPC分类号: C07D471/04 , C07C237/26 , C07C251/48 , C07C255/59 , C07C259/10 , C07C271/18 , C07C271/22 , C07C271/24 , C07C2601/02 , C07C2603/46 , C07D207/335 , C07D207/337 , C07D211/70 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/73 , C07D213/74 , C07D213/84 , C07D231/12 , C07D233/64 , C07D239/26 , C07D239/42 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/28 , C07D277/30 , C07D295/096 , C07D295/155 , C07D295/192 , C07D307/46 , C07D307/52 , C07D307/54 , C07D309/14 , C07D333/20 , C07D333/24 , C07D333/38 , C07D403/06 , C07D405/06 , C07D405/12 , C07D413/12 , C07D487/04
摘要: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
摘要翻译: 本发明至少部分地涉及新的取代的四环素化合物。 这些四环素化合物可用于治疗许多四环素化合物反应状态,例如细菌感染和肿瘤,以及四环素化合物的其它已知应用,例如阻断四环素外排和调节基因表达。
-
公开(公告)号:US20060166945A1
公开(公告)日:2006-07-27
申请号:US11258622
申请日:2005-10-25
申请人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Ismail , Mark Nelson , Kwasi Ohemeng , Jingwen Pan
发明人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Ismail , Mark Nelson , Kwasi Ohemeng , Jingwen Pan
IPC分类号: C07C237/26 , A61K31/65
CPC分类号: C07D471/04 , C07C237/26 , C07C251/48 , C07C255/59 , C07C259/10 , C07C271/18 , C07C271/22 , C07C271/24 , C07C2601/02 , C07C2603/46 , C07D207/335 , C07D207/337 , C07D211/70 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/73 , C07D213/74 , C07D213/84 , C07D231/12 , C07D233/64 , C07D239/26 , C07D239/42 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/28 , C07D277/30 , C07D295/096 , C07D295/155 , C07D295/192 , C07D307/46 , C07D307/52 , C07D307/54 , C07D309/14 , C07D333/20 , C07D333/24 , C07D333/38 , C07D403/06 , C07D405/06 , C07D405/12 , C07D413/12 , C07D487/04
摘要: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
-
公开(公告)号:US20140155357A1
公开(公告)日:2014-06-05
申请号:US13918197
申请日:2013-06-14
申请人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng , Jingwen Pan
发明人: Paul Abato , Haregewein Assefa , Joel Berniac , Beena Bhatia , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman , Mohamed Y. Ismail , Mark L. Nelson , Kwasi Ohemeng , Jingwen Pan
IPC分类号: C07D471/04 , C07C237/26 , C07D277/30 , C07D207/337 , C07D213/73 , C07D231/12 , C07D211/70 , C07D307/54
CPC分类号: C07D471/04 , C07C237/26 , C07C251/48 , C07C255/59 , C07C259/10 , C07C271/18 , C07C271/22 , C07C271/24 , C07C2601/02 , C07C2603/46 , C07D207/335 , C07D207/337 , C07D211/70 , C07D213/30 , C07D213/38 , C07D213/61 , C07D213/73 , C07D213/74 , C07D213/84 , C07D231/12 , C07D233/64 , C07D239/26 , C07D239/42 , C07D241/12 , C07D261/08 , C07D263/32 , C07D277/28 , C07D277/30 , C07D295/096 , C07D295/155 , C07D295/192 , C07D307/46 , C07D307/52 , C07D307/54 , C07D309/14 , C07D333/20 , C07D333/24 , C07D333/38 , C07D403/06 , C07D405/06 , C07D405/12 , C07D413/12 , C07D487/04
摘要: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
摘要翻译: 本发明至少部分地涉及新的取代的四环素化合物。 这些四环素化合物可用于治疗许多四环素化合物反应状态,例如细菌感染和肿瘤,以及四环素化合物的其他已知应用,例如阻断四环素外排和调节基因表达。
-
公开(公告)号:US20100305072A1
公开(公告)日:2010-12-02
申请号:US11963540
申请日:2007-12-21
申请人: Oak K. Kim , Mark L. Nelson , Paul Abato , Haregewein Assefa , Joel Bernaiac , Mohamed Y. Ismail , Todd Bowser , Mark Grier , Beena Bhatia , Atul K. Verma , Laura Honeyman , Jingwen Pan
发明人: Oak K. Kim , Mark L. Nelson , Paul Abato , Haregewein Assefa , Joel Bernaiac , Mohamed Y. Ismail , Todd Bowser , Mark Grier , Beena Bhatia , Atul K. Verma , Laura Honeyman , Jingwen Pan
IPC分类号: A61K31/65 , C07C237/26 , C07D211/34 , C07D265/30 , A61P31/00
CPC分类号: C07C237/26 , C07C2603/46 , C07D207/20 , C07D207/50 , C07D211/14 , C07D231/12 , C07D239/20 , C07D239/26 , C07D241/12 , C07D261/02 , C07D261/04 , C07D263/32 , C07D265/02 , C07D265/30 , C07D295/13 , C07D307/52
摘要: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
摘要翻译: 本发明至少部分地涉及新的取代的四环素化合物。 这些四环素化合物可用于治疗许多四环素化合物反应状态,如细菌感染和赘生物。
-
公开(公告)号:US20070093455A1
公开(公告)日:2007-04-26
申请号:US11490867
申请日:2006-07-21
申请人: Paul Abato , Haregewein Assefa , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman
发明人: Paul Abato , Haregewein Assefa , Joel Berniac , Todd Bowser , Jackson Chen , Mark Grier , Laura Honeyman
IPC分类号: A61K31/65 , C07C237/26
CPC分类号: C07D295/155 , C07C237/26 , C07C309/65 , C07D207/06 , C07D211/14 , C07D239/26 , C07D263/58 , C07D265/12 , C07D307/77 , C07D307/81
摘要: 10-Substituted tetracycline compounds are described.
摘要翻译: 描述了10-取代的四环素化合物。
-
10.
公开(公告)号:US07405235B2
公开(公告)日:2008-07-29
申请号:US10700661
申请日:2003-11-03
申请人: Stuart B. Levy , Michael N. Alekshun , Brent L. Podlogar , Kwasi Ohemeng , Atul K. Verma , Tadeusz Warchol , Beena Bhatia , Todd Bowser , Mark Grier
发明人: Stuart B. Levy , Michael N. Alekshun , Brent L. Podlogar , Kwasi Ohemeng , Atul K. Verma , Tadeusz Warchol , Beena Bhatia , Todd Bowser , Mark Grier
IPC分类号: A61K31/415 , C07D235/00
CPC分类号: A61K31/40 , A61K31/407 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/425 , A61K31/44 , A61K31/47 , A61K31/4745 , A61K31/495 , A61K31/50 , A61K31/505 , A61K31/535 , A61K31/55 , A61K31/555 , Y02A50/401 , Y02A50/47 , Y02A50/471 , Y02A50/473 , Y02A50/475 , Y02A50/478 , Y02A50/481 , Y02A50/483
摘要: Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.
摘要翻译: 提供了可用作降低微生物的抗性,毒力或生长的抗感染药物的取代的苯并咪唑化合物。 制备和使用取代的苯并咪唑化合物的方法,以及其药物制剂,例如降低抗生素抗性和抑制生物膜。
-
-
-
-
-
-
-
-
-